Rare diseases
Investigational molecules
Locations
Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
FranceA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
FranceA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
FranceA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
FranceA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
FranceStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
FranceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
FranceA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
FranceA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
